Dean Irwin

Surgical Laser Technologies, Inc. manufactures proprietary laser systems for both contact and non-contact surgery. The company is headquartered in Malvern, PA.

Micro Therapeutics, Inc. develops, manufactures and markets invasive medical devices for the diagnosis and treatment of vascular diseases. Its products include infusion catheters, ballon catheters, delivery catheters, guide wires, infusion wires, and thrombolytic brushes. The company was founded in 1993 and is headquartered in Irvine, CA

Luxtera, Inc. engages in the development and delivery of silicon complementary metal-oxide-semiconductor (CMOS) photonics. Its CMOS technology provides bandwidth for applications ranging from local area network to chip-to-chip interconnect. The company was founded by Alex Dickinson, Axel Scherer, Eli Yablonovitch and Lawrence Cary Gunn III in 2001 and is headquartered in Carlsbad, CA.

ClariPhy Communications, Inc. develops mixed-signal CMOS integrated circuits for networking applications. It also develops mixed signal, advanced digital signal processing SoCs targeting multi-mode, multi-rate high performance optical network applications at 10, 40, 100, and 200G via the industry's most comprehensive product portfolio. The company provides CL1012, a clock and data recovery integrated circuit for metro, regional, and long haul telecom networks; CL1012 evaluation board, a tool used to test and analyze maximum likelihood sequence estimated electronic dispersion compensation technology in combination with XFP modules; CL4010 LightSpeed, a coherent single chip dual polarization quadrature phase shift keying transceiver; and custom system-on-chips. ClariPhy Communications was founded by Paul Voois, Norm Swenson and Bharath Jagannathan on September 19, 2002 and is headquartered in Irvine, CA.

MiCardia Corp. designs, develops, and commercializes implantable medical devices. The firm offers implantable devices for the treatment of heart diseases, such as mitral valve regurgitation and congestive heart failure. It also provides enCor, an annuloplasty device that corrects residual mitral regurgitation on a beating heart. The company was founded in November 2004 by Michael R. Henson, Shawn Moaddeb and Samuel M. Shaolian and is headquartered in Irvine, CA.

Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Finistere Ventures LLC (Finistere Ventures) is a venture capital firm founded by Spencer Maughan and Arama Kukutai in 2005. The firm is headquartered in Newport Beach, California.

Headquartered in New York City, Crystal Research Associates is an independent research company dedicated to increasing the visibility of innovative and growing private and public companies. They focus on companies demonstrating solid growth prospects, well-designed operating and growth strategies, an experienced and proven management team, command of a niche position in a large and expanding market, and a unique or innovative position or technology. The firm was founded in 2003

American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC.

California Medical Association is an organization that represents over 50,000 physicians in California across various modes of practice and specialties. The non-profit company is based in Sacramento, CA and has subsidiaries in the United States. The company is dedicated to improving the health of all patients in the state. The CEO of the company is Dustin Corcoran.

Embrella Cardiovascular, Inc. develops proprietary systems for embolic cerebral protection during cardiovascular procedures. The company was founded by Judith T. Carpenter and Jeffrey Francis O'Donnell, Sr. in 2007 and is headquartered in Wayne, PA.

National Council for Community Development, Inc. provides technical assistance, professional training, small-business lending, debt and equity financing for residential, commercial, public, and nonprofit facilities. The company was founded in 1969 and is headquartered in New York, NY.

Cryotherapeutics SA develops and markets a cryotherapy system, with focus on highlighting the safety and efficacy of cryoneergy in the cardiovascular system. The firm specializes in the design of a proprietary system to be used in the treatment of coronary artery diseases that cause heart attacks. Its focus areas encompass technology research, system development, and early-stage product commercialization. The company was founded by Randell L. Werneth, John Yianni and Maurice Buchbinder on September 8, 2009 and is headquartered in Cologne, Germany.

Part of US Patent Innovations LLC, US Medical Innovations LLC is a privately held FDA registered life science, biomedical and robotic device company based in Takoma Park, MD. US Medical Innovations is dedicated to expanding the boundaries of plasma medicine by pioneering new technologies for the development of state-of-the-art medical devices that advance patient outcomes and improve human lives. The company develops products for laparoscopic, robotic and cancer surgeries. The company was founded in 2009 by Jerome Canady and Kimberly Wiley, with Jerome Canady serving as CEO since then.

Cra Advisors LLC provides investment advisory services. The private company is based in New York. The American company was founded by Jeffrey J. Kraws. Jeffrey J. Kraws has been the CEO since incorporation.

Part of Delek Group Ltd., Phoenix Holdings Ltd. (US) is a company that provides financial services. The company is based in Austin, TX.

TopHat Capital LLC is a financial services firm that operates as an execution-based company. The private company is based in New York, NY. The company was founded by Jeffrey J. Kraws.

Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020.